首页> 外文期刊>Journal of clinical virology: The official publication of the Pan American Society for Clinical Virology >Performance of an alternative laboratory-based algorithm for diagnosis of HIV infection utilizing a third generation immunoassay, a rapid HIV-1/HIV-2 differentiation test and a DNA or RNA-based nucleic acid amplification test in persons with established HIV-1 infection and blood donors
【24h】

Performance of an alternative laboratory-based algorithm for diagnosis of HIV infection utilizing a third generation immunoassay, a rapid HIV-1/HIV-2 differentiation test and a DNA or RNA-based nucleic acid amplification test in persons with established HIV-1 infection and blood donors

机译:使用第三代免疫测定法,快速HIV-1 / HIV-2分化测试以及基于DNA或RNA的核酸扩增测试对已确诊HIV-1感染者进行实验室诊断的替代算法的性能献血者

获取原文
获取原文并翻译 | 示例
           

摘要

Background: The HIV-1 Western blot (WB) and immunofluorescence assay used to confirm HIV infections are less sensitive during seroconversion than immunoassays (IAs) used for screening. An alternative diagnostic algorithm has been proposed to detect early HIV-1 infection and differentiate HIV-1 from HIV-2. Objectives: We evaluated the performance of an algorithm with a third generation IA that when reactive was followed by a rapid test (Multispot) that differentiates HIV-1 from HIV-2. Multispot-reactive specimens were considered HIV-infected. Multispot-negative specimens were tested with a nucleic acid amplification test (NAAT) for resolution. Study design: WB-positive specimens [serum (n= 2202), plasma (n= 1109) and peripheral blood mononuclear cells (PBMCs) (n= 1065)] were obtained from HIV-infected persons not taking antiretrovirals. HIV-uninfected specimens [plasma (n= 1517) and PBMCs (n= 1508)] with negative IA and NAAT results were obtained from blood donors. Specimens were tested with third generation IAs (Abbott rDNA, ADVIA Centaur, GS HIV1-2 Plus O, Ortho VITROS) in singlet, Multispot, and NAAT (APTIMA (RNA) and AMPLICOR (DNA)). We calculated algorithm sensitivity and specificity and the proportion of IA-reactive specimens requiring NAAT. Results: Algorithm sensitivity was 99.95% with APTIMA and 100% with AMPLICOR. One WB-positive specimen reactive by all IAs and AMPLICOR was negative by Multispot and APTIMA. Algorithm specificity was 100% using APTIMA or AMPLICOR as NAAT. From 0.10% (Abbott) to 2.43% (VITROS) of IA-reactive specimens required NAAT. Conclusions: The proposed algorithm performs with high sensitivity and specificity in specimens from persons with established HIV infection and uninfected blood donors and appears to be a good alternative to the current algorithm.
机译:背景:用于确认HIV感染的HIV-1 Western印迹(WB)和免疫荧光测定在血清转化过程中的敏感性低于用于筛选的免疫测定(IAs)。已经提出了另一种诊断算法来检测早期HIV-1感染并将HIV-1与HIV-2区分。目标:我们评估了第三代IA算法的性能,该算法在反应性之后进行快速测试(Multispot),以区分HIV-1和HIV-2。具有多点反应性的标本被认为感染了HIV。使用核酸扩增测试(NAAT)测试多点阴性样本的分离度。研究设计:WB阳性标本[血清(n = 2202),血浆(n = 1109)和外周血单个核细胞(PBMC)(n = 1065)]是从未服用抗逆转录病毒药物的HIV感染者那里获得的。从献血者那里获得了IA和NAAT结果均为阴性的未感染HIV的标本[血浆(n = 1517)和PBMC(n = 1508)]。使用第三代IA(Abbott rDNA,ADVIA Centaur,GS HIV1-2 Plus O,Ortho VITROS)以单峰,多斑点和NAAT(APTIMA(RNA)和AMPLICOR(DNA))测试样品。我们计算了算法的敏感性和特异性以及需要NAAT的IA反应性标本的比例。结果:APTIMA算法的灵敏度为99.95%,AMPLICOR算法的灵敏度为100%。所有IA和AMPLICOR均反应的1个WB阳性标本被Multispot和APTIMA阴性。使用APTIMA或AMPLICOR作为NAAT的算法特异性为100%。 IA反应性样本的0.10%(Abbott)至2.43%(VITROS)需要NAAT。结论:所提出的算法在HIV感染者和未感染献血者的标本中具有很高的灵敏度和特异性,似乎是当前算法的一个很好的选择。

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号